Updated JCVI Guidance –  Covid vaccination of children and young people aged 12- 17 years

Updated JCVI Guidance – Covid vaccination of children and young people aged 12- 17 years

Dear members

Please see updated Guidance from the JCVI

https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years

in addition to previous advice

https://www.gov.uk/government/publications/covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years-jcvi-statement

At this time,

  • the Pfizer-BioNTech BNT162b2 vaccine is the only vaccine authorised for persons aged 12 to 17 years in the UK
  • JCVI advises that all 16 to 17-year-olds should be offered a first dose of Pfizer-BNT162b2 vaccine. 
  • Persons aged 12 to 15 years with specific underlying health conditions that put them at risk of severe COVID-19, should be offered 2 doses of Pfizer-BNT162b2 vaccine with an interval of 8 weeks between doses.

This currently includes children with severe neuro-disabilities, Down’s Syndrome, underlying conditions resulting in immunosuppression, profound and multiple learning disabilities (PMLD), severe learning disabilities or who are on the learning disability register. Details regarding additional person-groups with underlying health conditions to be offered vaccination will be provided as updates in the Green Book.

Children and young people aged 12 years and over who are household contacts of persons (adults or children) who are immunosuppressed should be offered 2 doses of Pfizer-BNT162b2 vaccine.

The rollout of Covid vaccination in England will be led through primary care. The letter notes: “We recognise that not all eligible 12-15 year olds may be identified through the GP record. Therefore, any approach by parents of children at increased risk should be considered and clinical judgement used around eligibility in line with JCVI advice. In addition, trusts may refer 12-15 year olds for a COVID-19 vaccination if they consider them to be eligible”

Letter to primary care –
https://www.england.nhs.uk/coronavirus/publication/covid-19-vaccination-programme-actions-for-all-practices-to-support-vaccinating-eligible-12-15-year-olds/

FAQs on Vaccination delivery operations
https://www.england.nhs.uk/coronavirus/publication/vaccinating-children-and-young-people-faq

Best wishes

Sue

Dr S Protheroe
BSPGHAN President

Environmental Enteropathy- Paul Kelly

Environmental Enteropathy- Paul Kelly

BSPGHAN Education Series Videos

Environmental Enteropathy- Paul Kelly

This is a recording of the the CAPGAN/ BSPGHAN webinar delivered by Professor Paul Kelly, Professor of Tropical Gastroenterology at Barts & The London School of Medicine, UK on 1 July 2021. Produced by KYL.

RCPCH COVID Vaccination Update

The College has recently updated its webpage on the COVID-19 vaccine programme with some FAQs. This is available alongside advice for paediatricians published earlier this year on the eligibility of children and young people for COVID-19 vaccines in phase 1 of the programme. We're continuing to monitor these issues and will update the FAQ page as the situation develops.

With best wishes,

Kate
Kate Webb
Health Policy Lead
Royal College of Paediatrics and Child Health

Contact Us  l  Privacy Policy  l  Members Login  

© 2021 British Society of Paediatric Gastroenterology, Hepatology and Nutrition  l Charity Number 299294 l VAT registration number 323665308
Website design and development by KYL.